Tags

Type your tag names separated by a space and hit enter

Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times.
Leadersh Health Serv (Bradf Engl). 2021 11 19; ahead-of-print(ahead-of-print)LH

Abstract

PURPOSE

In January 2021, India launched the world's most extensive vaccination campaign against COVID-19. It is estimated that India would need to vaccinate over a billion people to achieve herd immunity. Even though the Indian Government focuses on improving and delivering its vaccination programme, significant challenges still exist. This paper aims to discuss current challenges to scale up India's vaccination campaign and addresses strategies for achieving this.

DESIGN/METHODOLOGY/APPROACH

The paper is based on a review of secondary sources, including journal articles from scholarly and grey literature and information available in the public domain. The search focused explicitly on the COVID-19 scenario, vaccination programme, public health management and systems leadership in the Indian health care system.

FINDINGS

The analysis revealed that various factors have disrupted India's vaccination campaign, including shortage of vaccine doses, mandatory prior online registration, lack of infrastructure, safety concerns for older people, untrained workforce and absence of a solid public health framework. Furthermore, India appears to have struggled to reduce tensions and instill trust in its ability to effectively manage the COVID-19 pandemic and vaccination programme due to a lack of cooperation between union government, state governments and other stakeholders, namely, policymakers, hospitals, industry and community.

ORIGINALITY/VALUE

The findings indicate that scaling up India's anti-COVID vaccination programme would require system-level leadership strategies that work within the country's limited resources. Deeper reforms in vaccine development, storage, delivery, training and regulatory frameworks are also needed to extend the world's largest anti-COVID-19 vaccination campaign.

Authors+Show Affiliations

All India Institute of Medical Sciences, New Delhi, India.Department of Educational Development and Research, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands and Department of Pediatrics, Dr Horacio E Oduber Hospital, Oranjestad, Aruba.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

34787981

Citation

Gulati, Kamal, and Jamiu Busari. "Vaccinating a Billion People Against COVID-19: India's Quest for Systems Leadership in Exceptional Times." Leadership in Health Services (Bradford, England), vol. ahead-of-print, no. ahead-of-print, 2021.
Gulati K, Busari J. Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times. Leadersh Health Serv (Bradf Engl). 2021;ahead-of-print(ahead-of-print).
Gulati, K., & Busari, J. (2021). Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times. Leadership in Health Services (Bradford, England), ahead-of-print(ahead-of-print). https://doi.org/10.1108/LHS-05-2021-0045
Gulati K, Busari J. Vaccinating a Billion People Against COVID-19: India's Quest for Systems Leadership in Exceptional Times. Leadersh Health Serv (Bradf Engl). 2021 11 19;ahead-of-print(ahead-of-print) PubMed PMID: 34787981.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccinating a billion people against COVID-19: India's quest for systems leadership in exceptional times. AU - Gulati,Kamal, AU - Busari,Jamiu, PY - 2021/11/17/entrez PY - 2021/11/18/pubmed PY - 2021/11/23/medline KW - COVID-19 KW - Health systems KW - India KW - Systems leadership KW - Vaccine JF - Leadership in health services (Bradford, England) JO - Leadersh Health Serv (Bradf Engl) VL - ahead-of-print IS - ahead-of-print N2 - PURPOSE: In January 2021, India launched the world's most extensive vaccination campaign against COVID-19. It is estimated that India would need to vaccinate over a billion people to achieve herd immunity. Even though the Indian Government focuses on improving and delivering its vaccination programme, significant challenges still exist. This paper aims to discuss current challenges to scale up India's vaccination campaign and addresses strategies for achieving this. DESIGN/METHODOLOGY/APPROACH: The paper is based on a review of secondary sources, including journal articles from scholarly and grey literature and information available in the public domain. The search focused explicitly on the COVID-19 scenario, vaccination programme, public health management and systems leadership in the Indian health care system. FINDINGS: The analysis revealed that various factors have disrupted India's vaccination campaign, including shortage of vaccine doses, mandatory prior online registration, lack of infrastructure, safety concerns for older people, untrained workforce and absence of a solid public health framework. Furthermore, India appears to have struggled to reduce tensions and instill trust in its ability to effectively manage the COVID-19 pandemic and vaccination programme due to a lack of cooperation between union government, state governments and other stakeholders, namely, policymakers, hospitals, industry and community. ORIGINALITY/VALUE: The findings indicate that scaling up India's anti-COVID vaccination programme would require system-level leadership strategies that work within the country's limited resources. Deeper reforms in vaccine development, storage, delivery, training and regulatory frameworks are also needed to extend the world's largest anti-COVID-19 vaccination campaign. SN - 1751-1887 UR - https://www.unboundmedicine.com/medline/citation/34787981/Vaccinating_a_billion_people_against_COVID_19:_India's_quest_for_systems_leadership_in_exceptional_times_ L2 - https://medlineplus.gov/covid19coronavirusdisease2019.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.